The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Aldosterone: effects on the kidney and cardiovascular system
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
PITT, B., ZANNAD, F., REMME, W. J., CODY, R., CASTAIGNE, A., PEREZ, A., PALENSKY, J., & WITTES, J. (2000) · Survey of Anesthesiology · doi:10.1097/00132586-200006000-00059 · Cited by 2,927
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study
Juurlink, D. N., Mamdani, M. M., Lee, D. S., Kopp, A., Austin, P. C., Laupacis, A., & Redelmeier, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040135 · Cited by 1,761
Strict Blood-Pressure Control and Progression of Renal Failure in Children
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902066 · Cited by 956
Aldosterone induces a vascular inflammatory phenotype in the rat heart
Rocha, R., Rudolph, A. E., Frierdich, G. E., Nachowiak, D. A., Kekec, B. K., Blomme, E. A. G., McMahon, E. G., & Delyani, J. A. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01096.2001 · Cited by 655
Ruggenenti, P., Perna, A., Gherardi, G., Gaspari, F., Benini, R., & Remuzzi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04433-x · Cited by 574
Aldosterone-Induced Inflammation in the Rat Heart
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., & Weber, K. T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64454-9 · Cited by 567
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats
Blasi, E. R., Rocha, R., Rudolph, A. E., Blomme, E. A. G., Polly, M. L., & McMahon, E. G. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00929.x · Cited by 542
Farquharson, C. A. J., & Struthers, A. D. (2000) · Circulation · doi:10.1161/01.cir.101.6.594 · Cited by 532
Mineralocorticoid excess, dietary sodium, and myocardial fibrosis.
Brilla, C. G., & Weber, K. T. (1992) · PubMed · Cited by 505
Plasma sodium stiffens vascular endothelium and reduces nitric oxide release
Oberleithner, H., Riethmüller, C., Schillers, H., MacGregor, G. A., de Wardener, H. E., & Hausberg, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707791104 · Cited by 480
Role of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Shibata, S., Nagase, M., Yoshida, S., Kawarazaki, W., Kurihara, H., Tanaka, H., Miyoshi, J., Takai, Y., & Fujita, T. (2008) · Nature Medicine · doi:10.1038/nm.1879 · Cited by 459
Selective Aldosterone Blockade with Eplerenone Reduces Albuminuria in Patients with Type 2 Diabetes
Epstein, M., Williams, G. H., Weinberger, M., Lewin, A., Krause, S., Mukherjee, R., Patni, R., & Beckerman, B. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00240106 · Cited by 459
Mineralocorticoids, hypertension, and cardiac fibrosis.
Young, M., Fullerton, M., Dilley, R., & Funder, J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117269 · Cited by 437
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Self-citationPodocyte as the Target for Aldosterone: Roles of Oxidative Stress and Sgk1
Shibata, S., Nagase, M., Yoshida, S., Kawachi, H., & Fujita, T. (2007) · Hypertension · doi:10.1161/01.hyp.0000255636.11931.a2 · Cited by 362
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 358
NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat
Beswick, R. A., Dorrance, A. M., Leite, R., & Webb, R. C. (2001) · Hypertension · doi:10.1161/hy1101.093423 · Cited by 347
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Leopold, J. A., Dam, A., Maron, B. A., Scribner, A. W., Liao, R., Handy, D. E., Stanton, R. C., Pitt, B., & Loscalzo, J. (2007) · Nature Medicine · doi:10.1038/nm1545 · Cited by 346
Bianchi, S., Bigazzi, R., & Campese, V. M. (2006) · Kidney International · doi:10.1038/sj.ki.5001854 · Cited by 338
Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., Shah, A. M., Johar, S., Cave, A. C., Narayanapanicker, A., Grieve, D. J., & Shah, A. M. (2006) · The FASEB Journal · doi:10.1096/fj.05-4642fje · Cited by 318
Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000118519.66430.22 · Cited by 314
Role of Aldosterone in Renal Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Zuckerman, A., & Stier, C. T. (1999) · Hypertension · doi:10.1161/01.hyp.33.1.232 · Cited by 310
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.
Lombès, M., Oblin, M. E., Gasc, J. M., Baulieu, E. E., Farman, N., & Bonvalet, J. P. (1992) · Circulation Research · doi:10.1161/01.res.71.3.503 · Cited by 309
Rocha, R., Martin-Berger, C. L., Yang, P., Scherrer, R., Delyani, J., & McMahon, E. (2002) · Endocrinology · doi:10.1210/en.2002-220120 · Cited by 308
Albuminuria in chronic heart failure: prevalence and prognostic importance
Jackson, C. E., Solomon, S. D., Gerstein, H. C., Zetterstrand, S., Olofsson, B., Michelson, E. L., Granger, C. B., Swedberg, K., Pfeffer, M. A., Yusuf, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61378-7 · Cited by 308
Rickard, A. J., Morgan, J., Tesch, G., Funder, J. W., Fuller, P. J., & Young, M. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.131110 · Cited by 303
Eijkelkamp, W. B. A., Zhang, Z., Remuzzi, G., Parving, H.-H., Cooper, M. E., Keane, W. F., Shahinfar, S., Gleim, G. W., Weir, M. R., Brenner, B. M., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050445 · Cited by 302
Rossing, K., Schjoedt, K. J., Smidt, U. M., Boomsma, F., & Parving, H.-H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2106 · Cited by 299
Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.04.029 · Cited by 298
Edwards, N. C., Steeds, R. P., Stewart, P. M., Ferro, C. J., & Townend, J. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.03.066 · Cited by 286
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Iraqi, W., Rossignol, P., Angioi, M., Fay, R., Nuée, J., Ketelslegers, J. M., Vincent, J., Pitt, B., & Zannad, F. (2009) · Circulation · doi:10.1161/circulationaha.108.809194 · Cited by 260
Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo
Brown, N. J., Nakamura, S., Ma, L., Nakamura, I., Donnert, E., Freeman, M., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00277.x · Cited by 255
Lambers Heerspink, H. J., Brantsma, A. H., de Zeeuw, D., Bakker, S. J. L., de Jong, P. E., Gansevoort, R. T., & for the PREVEND Study Group (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn209 · Cited by 253
Nagase, M., Shibata, S., Yoshida, S., Nagase, T., Gotoda, T., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000222003.28517.99 · Cited by 248
Aldosterone Activates Vascular p38MAP Kinase and NADPH Oxidase Via c-Src
Callera, G. E., Touyz, R. M., Tostes, R. C., Yogi, A., He, Y., Malkinson, S., & Schiffrin, E. L. (2005) · Hypertension · doi:10.1161/01.hyp.0000154365.30593.d3 · Cited by 246
Self-citationNOX2 and NOX4 Mediate Proliferative Response in Endothelial Cells
Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J., & Görlach, A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1473 · Cited by 243
Beneficial impact of spironolactone in diabetic nephropathy
Schjoedt, K. J., Rossing, K., Juhl, T. R., Boomsma, F., Rossing, P., Tarnow, L., & Parving, H.-H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00756.x · Cited by 239
Development of Rho-kinase inhibitors for cardiovascular medicine
Shimokawa, H., & Rashid, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.04.006 · Cited by 238
Vascular Hypertrophy and Remodeling in Secondary Hypertension
Rizzoni, D., Porteri, E., Castellano, M., Bettoni, G., Muiesan, M. L., Muiesan, P., Giulini, S. M., & Agabiti-Rosei, E. (1996) · Hypertension · doi:10.1161/01.hyp.28.5.785 · Cited by 238
Pitt, B., Bakris, G., Ruilope, L. M., DiCarlo, L., & Mukherjee, R. (2008) · Circulation · doi:10.1161/circulationaha.108.778811 · Cited by 235
Robert, V., Heymes, C., Silvestre, J.-S., Sabri, A., Swynghedauw, B., & Delcayre, C. (1999) · Hypertension · doi:10.1161/01.hyp.33.4.981 · Cited by 230
FARQUHARSON, C. A. J., & STRUTHERS, A. D. (2002) · Clinical Science · doi:10.1042/cs1030425 · Cited by 224
Mineralocorticoid Receptor Antagonism in Experimental Atherosclerosis
Rajagopalan, S., Duquaine, D., King, S., Pitt, B., & Patel, P. (2002) · Circulation · doi:10.1161/01.cir.0000015854.60710.10 · Cited by 223
Nagata, K., Obata, K., Xu, J., Ichihara, S., Noda, A., Kimata, H., Kato, T., Izawa, H., Murohara, T., & Yokota, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000203772.78696.67 · Cited by 223
Bozkurt, B., Agoston, I., & Knowlton, A. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02694-3 · Cited by 223
Beswick, R. A., Zhang, H., Marable, D., Catravas, J. D., Hill, W. D., & Webb, R. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.781 · Cited by 221
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy
Schjoedt, K. J., Rossing, K., Juhl, T. R., Boomsma, F., Tarnow, L., Rossing, P., & Parving, H. H. (2006) · Kidney International · doi:10.1038/sj.ki.5001580 · Cited by 215
Chrysostomou, A., Pedagogos, E., MacGregor, L., & Becker, G. J. (2006) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01040905 · Cited by 211
Nongenomic Vascular Action of Aldosterone in the Glomerular Microcirculation
Arima, S., Kohagura, K., Xu, H.-L., Sugawara, A., Abe, T., Satoh, F., Takeuchi, K., & Ito, S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000083982.74108.54 · Cited by 202
Nongenomic Effects of Aldosterone on Intracellular Ca2+in Vascular Smooth Muscle Cells
Wehling, M., Neylon, C. B., Fullerton, M., Bobik, A., & Funder, J. W. (1995) · Circulation Research · doi:10.1161/01.res.76.6.973 · Cited by 190
van den Meiracker, A. H., Baggen, R. G., Pauli, S., Lindemans, A., Vulto, A. G., Poldermans, D., & Boomsma, F. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249708.44016.5c · Cited by 187
Prevention of Aortic Fibrosis by Spironolactone in Spontaneously Hypertensive Rats
Benetos, A., Lacolley, P., & Safar, M. E. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1152 · Cited by 186
Spironolactone prevents early renal injury in streptozotocin-induced diabetic rats
Fujisawa, G., Okada, K., Muto, S., Fujita, N., Itabashi, N., Kusano, E., & Ishibashi, S. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00913.x · Cited by 179
Regression of Existing Glomerulosclerosis by Inhibition of Aldosterone
Aldigier, J. C., Kanjanbuch, T., Ma, L.-J., Brown, N. J., & Fogo, A. B. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004090804 · Cited by 171
Loffing, J., & Korbmacher, C. (2009) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0656-0 · Cited by 170
Min, L.-J., Mogi, M., Li, J.-M., Iwanami, J., Iwai, M., & Horiuchi, M. (2005) · Circulation Research · doi:10.1161/01.res.0000180753.63183.95 · Cited by 170
Luther, J. M., Gainer, J. V., Murphey, L. J., Yu, C., Vaughan, D. E., Morrow, J. D., & Brown, N. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000248135.97380.76 · Cited by 169
Savoia, C., Touyz, R. M., Amiri, F., & Schiffrin, E. L. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.103267 · Cited by 169
Self-citationMontezano, A. C., Callera, G. E., Yogi, A., He, Y., Tostes, R. C., He, G., Schiffrin, E. L., & Touyz, R. M. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.168021 · Cited by 166
Self-citationLocal Angiotensin II and Transforming Growth Factor-β1 in Renal Fibrosis of Rats
Sun, Y., Zhang, J., Zhang, J. Q., & Ramires, F. J. A. (2000) · Hypertension · doi:10.1161/01.hyp.35.5.1078 · Cited by 166
Liu, S. L., Schmuck, S., Chorazcyzewski, J. Z., Gros, R., & Feldman, R. D. (2003) · Circulation · doi:10.1161/01.cir.0000093188.53554.44 · Cited by 164
Kretzler, M., Koeppen-Hagemann, I., & Kriz, W. (1994) · Virchows Archiv · doi:10.1007/bf00230355 · Cited by 158
Iglarz, M., Touyz, R. M., Viel, É. C., Amiri, F., & Schiffrin, E. L. (2004) · PubMed · Cited by 158
Self-citationNagai, Y., Miyata, K., Sun, G.-P., Rahman, M., Kimura, S., Miyatake, A., Kiyomoto, H., Kohno, M., Abe, Y., Yoshizumi, M., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000174593.88899.68 · Cited by 158
Nagase, M., Matsui, H., Shibata, S., Gotoda, T., & Fujita, T. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.091058 · Cited by 157
Nishiyama, A., Yao, L., Fan, Y.-Y., Kyaw, M. H., Kataoka, N., Hashimoto, K., Nagai, Y., Nakamura, E., Yoshizumi, M., Shokoji, T., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154681.38944.9a · Cited by 152
Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats
Lacolley, P. J., Safar, M. E., Lucet, B., Dudal, K. L., Labat, C., & Bénétos, A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01129-3 · Cited by 149
Reconsidering the Roles of the Mineralocorticoid Receptor
Funder, J. W. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.119966 · Cited by 149
Rozansky, D. J., Cornwall, T., Subramanya, A. R., Rogers, S. L., Yang, Y.-F., David, L. L., Zhu, X., Yang, C., & Ellison, D. H. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38323 · Cited by 148
Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin
Zhang, A., Jia, Z., Guo, X., & Yang, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00480.2006 · Cited by 146
Wall Stiffness Suppresses Akt/eNOS and Cytoprotection in Pulse-Perfused Endothelium
Peng, X., Haldar, S. M., Deshpande, S., Irani, K., & Kass, D. A. (2003) · Hypertension · doi:10.1161/01.hyp.0000049624.99844.3d · Cited by 145
VASCULAR TYPE I ALDOSTERONE BINDING SITES ARE PHYSIOLOGICAL MINERALOCORTICOID RECEPTORS
Funder, J. W., Pearce, P., Smith, R., & Campbell, J. H. (1989) · Endocrinology · doi:10.1210/endo-125-4-2224 · Cited by 144
Náray‐Fejes‐Tóth, A., Snyder, P. M., & Fejes‐Tóth, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408146101 · Cited by 139
Human Endothelium: Target for Aldosterone
Oberleithner, H., Ludwig, T. E., Riethmüller, C., Hillebrand, U., Albermann, L., Schäfer, C., Shahin, V., & Schillers, H. (2004) · Hypertension · doi:10.1161/01.hyp.0000123572.45556.a5 · Cited by 139
Aldosterone induces contraction of the resistance arteries in man
Romagni, P., Rossi, F., Guerrini, L., Quirini, C., & Santiemma, V. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00363-5 · Cited by 137
Park, Y. M., Park, M. Y., Suh, Y., & Park, J. B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.173 · Cited by 135
Aldosterone Induces Superoxide Generation via Rac1 Activation in Endothelial Cells
Iwashima, F., Yoshimoto, T., Minami, I., Sakurada, M., Hirono, Y., & Hirata, Y. (2007) · Endocrinology · doi:10.1210/en.2007-0864 · Cited by 134
Ruggenenti, P. L., Perna, A., Benini, R., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112096 · Cited by 127
Blanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126
Garnier, A., Bendall, J. K., Fuchs, S., Escoubet, B., Rochais, F., Hoerter, J. A., Nehmé, J., Ambroisine, M.-L., Angelis, N. D., Morineau, G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000142858.44680.27 · Cited by 125
Hayashi, H., Kobara, M., Masaki, A. B. E., Tanaka, N., Gouda, E., Toba, H., Yamada, H., Tatsumi, T., Nakata, T., & Matsubara, H. (2008) · Hypertension Research · doi:10.1291/hypres.31.363 · Cited by 123
Young, M. J., Moussa, L., Dilley, R., & Funder, J. W. (2003) · Endocrinology · doi:10.1210/en.2002-220926 · Cited by 121
Rapid Nongenomic Effects of Aldosterone on Human Forearm Vasculature
Schmidt, B. M. W., Oehmer, S., Delles, C., Bratke, R., Schneider, M. P., Klingbeil, A. U., Fleischmann, E. H., & Schmieder, R. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000083298.23119.16 · Cited by 120
Lea, W. B., Kwak, E. S., Luther, J. M., Fowler, S. M., Wang, Z., Ma, J., Fogo, A. B., & Brown, N. J. (2009) · Kidney International · doi:10.1038/ki.2009.9 · Cited by 118
Young, M. J., & Funder, J. W. (2004) · Endocrinology · doi:10.1210/en.2004-0005 · Cited by 112
Endemann, D., Touyz, R. M., Iglarz, M., Savoia, C., & Schiffrin, E. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000128031.31572.a3 · Cited by 109
Self-citationMasoudi, F. A., Gross, C. P., Wang, Y., Rathore, S. S., Havranek, E. P., Foody, J. M., & Krumholz, H. M. (2005) · Circulation · doi:10.1161/circulationaha.104.527549 · Cited by 108
Disinhibitory pathways for control of sodium transport: regulation of ENaC by SGK1 and GILZ
Bhalla, V., Soundararajan, R., Pao, A. C., Li, H., & Pearce, D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00061.2006 · Cited by 108
Jorde, U. P., Vittorio, T. J., Katz, S. D., Colombo, P. C., Latif, F., & Jemtel, T. H. L. (2002) · Circulation · doi:10.1161/01.cir.0000030935.89559.04 · Cited by 106
Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence
MIN, L., MOGI, M., IWANAMI, J., LI, J., SAKATA, A., FUJITA, T., TSUKUDA, K., IWAI, M., & HORIUCHI, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.008 · Cited by 105 · cited 1×
“have also reported a synergistic effect of angiotensin II and aldosterone on vascular smooth muscle cell senescence in a pathway that involves oxidative stress and Ki-Ras2A”
BackgroundTylicki, L., Rutkowski, P., Renke, M., Larczyński, W., Aleksandrowicz, E., Łysiak−Szydłowska, W., & Rutkowski, B. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.297 · Cited by 104
Stas, S. N., Whaley‐Connell, A. T., Habibi, J., Appesh, L., Hayden, M. R., Karuparthi, P. R., Qazi, M., Morris, E. M., Cooper, S. A., Link, C. D., et al. (2007) · Endocrinology · doi:10.1210/en.2006-1691 · Cited by 103
Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation
Huang, S., Zhang, A., Ding, G., & Chen, R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90428.2008 · Cited by 99
Effect of aldosterone on renal transforming growth factor-β
Juknevicius, I., Segal, Y., Kren, S. M., et al. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00202.2003 · Cited by 98
Furumatsu, Y., Nagasawa, Y., Tomida, K., Mikami, S., Kaneko, T., Okada, N., Tsubakihara, Y., Imai, E., & Shoji, T. (2008) · Hypertension Research · doi:10.1291/hypres.31.59 · Cited by 97
Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury
Ma, J., Weisberg, A. D., Griffin, J. P., Vaughan, D. E., Fogo, A. B., & Brown, N. J. (2006) · Kidney International · doi:10.1038/sj.ki.5000201 · Cited by 96
Lemarié, C. A., Simeone, S., Nikonova, A. S., Ebrahimian, T., Deschênes, M.-E., Coffman, T. M., Paradis, P., & Schiffrin, E. L. (2009) · Circulation Research · doi:10.1161/circresaha.109.196576 · Cited by 92
Self-citationSchiffrin, E. L., Gutkowska, J., & Genest, J. (1984) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1984.246.4.h608 · Cited by 86
Self-citationAldosterone-Stimulated SGK1 Activity Mediates Profibrotic Signaling in the Mesangium
Terada, Y., Kuwana, H., Kobayashi, T., Okado, T., Suzuki, N., Yoshimoto, T., Hirata, Y., & Sasaki, S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007050531 · Cited by 84
Nakano, S., Kobayashi, N., Yoshida, K., Tomoyuki, O. H. N. O., & Matsuoka, H. (2005) · Hypertension Research · doi:10.1291/hypres.28.925 · Cited by 81
Extended Prognostic Value of Urinary Albumin Excretion for Cardiovascular Events
Brantsma, A. H., Bakker, S. J. L., de Zeeuw, D., de Jong, P. E., & Gansevoort, R. T. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101065 · Cited by 81
Short Term Cardiovascular Effects of Aldosterone in Healthy Male Volunteers
Schmidt, B. M. W., Montealegre, A., Janson, C. P., Martin, N., Stein-Kemmesies, C., Scherhag, A. W., Feuring, M., Christ, M., & Wehling, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6020 · Cited by 79
Huang, W. G., Chen, X., Kahng, K. W., Noble, N. A., Border, W. A., & Huang, Y. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00017.2008 · Cited by 75
Nakamura, T., Kataoka, K., Fukuda, M., Nako, H., Tokutomi, Y., Dong, Y., Ichijo, H., Ogawa, H., & Kim‐Mitsuyama, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.135392 · Cited by 74
Lee, S. H., Yoo, T., Nam, B.-Y., Kim, D. K., Li, J. J., Jung, D.-S., Kwak, S.-J., Ryu, D., Han, S. H., Lee, J. E., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00101.2009 · Cited by 73
Xavier, F. E., Aras‐López, R., Arroyo-Villa, I., del Campo, L., Salaíces, M., Rossoni, L. V., Ferrer, M., & Balfagón, G. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.200 · Cited by 73
Siragy, H. M., & Xue, C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.042085 · Cited by 65
Spironolactone suppresses inflammation and prevents L-NAME–induced renal injury in rats
Ikeda, H., Tsuruya, K., Toyonaga, J., Masutani, K., Hayashida, H., Hirakata, H., & Iida, M. (2008) · Kidney International · doi:10.1038/ki.2008.507 · Cited by 65
Lai, L., Chen, J., Hao, C.-M., Lin, S.-T., & Gu, Y. (2006) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2006.07.057 · Cited by 64
Otani, H., Otsuka, F., Inagaki, K., Takeda, M., Miyoshi, T., Suzuki, J., Mukai, T., Ogura, T., & Makino, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00402.2006 · Cited by 60
Aldosterone activates endothelial exocytosis
Jeong, Y., Chaupin, D. F., Matsushita, K., Yamakuchi, M., Cameron, S. J., Morrell, C. N., & Lowenstein, C. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804037106 · Cited by 59
Imanishi, T., Ikejima, H., Tsujioka, H., Kuroi, A., Kobayashi, K., Muragaki, Y., Mochizuki, S., Goto, M., Yoshida, K., & Akasaka, T. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.104299 · Cited by 57
Whaley‐Connell, A. T., Habibi, J., Wei, Y., Gutweiler, A. A., Jellison, J., Wiedmeyer, C. E., Ferrario, C. M., & Sowers, J. R. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90646.2008 · Cited by 50
Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats.
Schiffrin, E. L., Thomé, F. S., & Genest, J. (1983) · Hypertension · doi:10.1161/01.hyp.5.6_pt_3.v16 · Cited by 49
Self-citationAldosterone Enhances Ligand-Stimulated Nitric Oxide Production in Endothelial Cells
Mutoh, A., Isshiki, M., & Fujita, T. (2008) · Hypertension Research · doi:10.1291/hypres.31.1811 · Cited by 47
Irita, J., Okura, T., Manabe, S., Kurata, M., MIYOSHI, K., Watanabe, S., FUKUOKA, T., & Higaki, J. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.08.019 · Cited by 46
Aldosterone up-regulates production of plasminogen activator inhibitor-1 by renal mesangial cells.
Yuan, J., Jia, R., & Bao, Y. (2007) · Journal of biochemistry and molecular biology · doi:10.5483/bmbrep.2007.40.2.180 · Cited by 45
Calò, L. A., Puato, M., Schiavo, S., Zanardo, M., Tirrito, C., Pagnin, E., Balbi, G., Davis, P. A., Palatini, P., & Pauletto, P. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn118 · Cited by 44
Nakamura, Y., Suzuki, S., Suzuki, T., Ono, K., Miura, I., Satoh, F., Moriya, T., Saito, H., Yamada, S., Ito, S., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051351 · Cited by 41
Influence of Acute and Chronic Mineralocorticoid Excess on Endothelial Function in Healthy Men
Nietlispach, F., Julius, B. K., Schindler, R., Bernheim, A., Binkert, C. A., Kiowski, W., & Rocca, H. B. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088955 · Cited by 39
Du, J. C., Fan, Y., Hitomi, H., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00197.2009 · Cited by 33
Renal aspirin: will all patients with chronic kidney disease one day take spironolactone?
Bomback, A. S., Kshirsagar, A. V., & Klemmer, P. J. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1004 · Cited by 22
Chun, T.-Y., Chander, P. N., Kim, J.-W., Pratt, J. H., & Stier, C. T. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2007 · Cited by 22
Targeting Proteinuria as a Valid Surrogate for Individualized Kidney Protective Therapy
de Zeeuw, D. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.03.013 · Cited by 18
Cited by
Association between insulin resistance and the development of cardiovascular disease
Ormazabal, V., Nair, S., Elfeky, O., Aguayo, C., Salomon, C., & Zuñiga, F. A. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0762-4 · Cited by 2,280
Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.18 · Cited by 1,230
Herzog, C. A., Asinger, R. W., Berger, A. K., Charytan, D. M., Díez, J., Hart, R. G., Eckardt, K.-U., Kasiske, B. L., McCullough, P. A., Passman, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 922
Cell Biology and Pathology of Podocytes
Greka, A., & Mundel, P. (2012) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153238 · Cited by 518
Renal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
Metadata
- Authors
- Briet, M., & Schiffrin, E. L.
- Venue
- Nature Reviews Nephrology
- Published
- 2010-03-16
- Volume
- 6
- Issue
- 5
- Pages
- 261-273
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W1974077099
- Cited by
- 337
- References
- 132
- FWCI
- 3.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.